(Q44853856)

6 December 2017

title

Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency (English)

1 reference

6 December 2017

1 reference

Christopher L Bowlus

1

1 reference

6 December 2017

Ira Willner

2

1 reference

6 December 2017

Mark A Zern

3

1 reference

6 December 2017

Adrian Reuben

4

1 reference

6 December 2017

Philip Chen

5

1 reference

6 December 2017

Brian Holladay

6

1 reference

6 December 2017

Lianqi Xie

7

1 reference

6 December 2017

Robert F Woolson

8

1 reference

6 December 2017

Charlie Strange

9

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Clinical Gastroenterology and Hepatology

6 December 2017

published in

1 reference

6 December 2017

volume

3

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

390-396

1 reference

Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Heterozygous MZ alpha-1-antitrypsin deficiency in adults with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Chronic 'cryptogenic' liver disease and malignant hepatoma in intermediate alpha 1-antitrypsin deficiency identified by a Pi Z-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Liver disease and intermediate alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Chronic liver disease in heterozygous alpha1-antitrypsin deficiency PiZ

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Heterozygous MZ alpha 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Liver investigation in 149 asymptomatic patients with moderately elevated activities of serum aminotransferases

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Molecular analysis of thePi*Z allele in patients with liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Heterozygous alpha 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Occurrence of Alpha-1-antitrypsin Deficiency in 155 Patients with Alcoholic Liver Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Alpha-1-Antitrypsin MZ Phenotype and Cryptogenic Chronic Liver Disease in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Liver Disease in Alpha1-Antitrypsin Deficiency Detected by Screening of 200,000 Infants

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Alpha 1-antitrypsin deficiency deaths in the United States from 1979-1991. An analysis using multiple-cause mortality data

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Liver disease in adults with alpha-1 -antitrypsin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Risk for liver disease in adults with alpha 1-antitrypsin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Alpha-1 Foundation research registry: from the past to the future

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Screening for alcohol abuse using CAGE scores and likelihood ratios

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Liver disease in alpha-1-antitrypsin deficiency: prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

TRANSPLANTATION FOR END STAGE LIVER DISEASE RELATED TO ALPHA 1 ANTITRYPSIN

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

An association between alpha 1-antitrypsin phenotype and chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

Contribution of obesity to hepatitis C-related fibrosis progression

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900082-0

7 January 2021

10.1016/S1542-3565(05)00082-0

Identifiers

DOI

1 reference

6 December 2017

1 reference